eXoZymes

Cell-Free Biomanufacturing

Process Route & Design Basis

FEL-1

AACE Class 5-4

eXoZymes pioneers AI-enhanced, cell-free biomanufacturing, using engineered enzyme cascades outside living cells to transform widely available feedstocks into high-value nutraceuticals, potential medicines, and other valuable compounds. Roebling modeled the economics and environmental footprint of a continuous manufacturing process and translated the findings into a FEL-1+ engineering design basis.

eXoZymes logo
eXoZymes logo

500+ scenarios

evaluated before aligning on one design basis for the FEL-1 package, compared to the one or two a typical firm would run

2 process designs

compared on CapEx, OpEx, and carbon footprint trade-offs

4 design levers

extraction route, make-vs-buy, energy sourcing, and recycling, tested on one basis

Challenge

Scaling eXoZymes' AI-enhanced, cell-free biomanufacturing platform required evaluating interconnected choices affecting capital investment, production costs, and environmental footprint. Key questions included product recovery, sourcing of critical inputs, energy options, and the economics of recycling process components.

Solution

Roebling developed an integrated techno-economic model connecting mass and energy balances, equipment sizing, material and utility requirements, capital costs, operating costs, and product carbon footprint. The model enabled consistent comparisons of alternative manufacturing configurations.

Results

The analysis helped eXoZymes select a preferred process route for FEL-1+ engineering and identify the variables with the greatest impact on cost of goods sold. These insights support focused engineering and R&D priorities as the company advances its asset-light commercialization strategy.

Deliverables

Process & Engineering

Basis of Design Report

One process route chosen from two competing designs.

Process Flow Diagrams

Delivered in the FEL-1+ package after the design basis was settled.

Mass & Energy Balance

Linked to equipment sizing, the equipment list, and the utility and chemical summary.

Equipment List

Carried forward from the same model without rebuilding the cost basis.

Raw Material & Utility Summary

Includes standard versus green energy sourcing and its effect on OpEx and carbon footprint.

Cost & Economics

TEM Summary Report

500+ scenarios across extraction route, make-vs-buy, energy sourcing, and recycling, with COGS sensitivity.

Scale & Project Planning

Pre-Development Planning Report

The plan for taking the selected design basis into the next phase.

Integrated Project Schedule

The project schedule, delivered in the FEL-1+ package.

Paul Opgenorth, VP of Development and Co-Founder of eXoZymes

"For a new manufacturing platform, the challenge is not just proving the technology works—it is understanding what will make it commercially competitive. Roebling helped us compare recovery, energy, and recycling options within one model and establish a defensible basis for the next phase of the project."

Paul Opgenorth, PhD

VP of Development & Co-Founder, eXoZymes

The Approach

One integrated model. Clearer decisions for commercial scale.

Each comparison ran through one connected model:

  • Compared two product recovery routes for the continuous, cell-free process, together with on-site production versus external sourcing of key inputs.

  • Evaluated conventional and lower-carbon energy options against operating costs and product carbon footprint.

  • Assessed the capital and operating cost implications of recycling critical process components at different production scales.

  • Used cost-of-goods sensitivity analysis to identify the process and site variables with the greatest influence on commercial economics.

Once eXoZymes aligned on the major design basis decisions, Roebling delivered the FEL-1+ engineering package: a basis of design report, process flow diagrams, equipment list, raw material and utility summary, and an integrated project schedule, carried forward from the same model without rebuilding the cost basis.

What the team says

"Our goal is to make cell-free biomanufacturing commercially scalable. By evaluating capital costs, operating costs, and carbon footprint together, we gained a clearer picture of the trade-offs that matter as we move toward commercialization."

Damien Perriman, Chief Commercial Officer of eXoZymes

Damien Perriman

Chief Commercial Officer, eXoZymes

"Our goal is to make cell-free biomanufacturing commercially scalable. By evaluating capital costs, operating costs, and carbon footprint together, we gained a clearer picture of the trade-offs that matter as we move toward commercialization."

Damien Perriman, Chief Commercial Officer of eXoZymes

Damien Perriman

Chief Commercial Officer, eXoZymes

"Our project with eXoZymes was remarkably complex. We modeled their cell-free process at commercial greenfield scale with multiple downstream product extraction methods selectable within the one model. That same singular model also included the ability to select whether or not to build an entire microbial fermentation facility alongside the cell-free facility to produce their own enzymes, as opposed to purchasing them as a raw material. All of these immensely impactful trade-offs could be analyzed by the simple flick of a few toggles in our model."

Nick Salvadore, Process Engineer II at Roebling

Nick Salvadore

Process Engineer II, Roebling

"Our project with eXoZymes was remarkably complex. We modeled their cell-free process at commercial greenfield scale with multiple downstream product extraction methods selectable within the one model. That same singular model also included the ability to select whether or not to build an entire microbial fermentation facility alongside the cell-free facility to produce their own enzymes, as opposed to purchasing them as a raw material. All of these immensely impactful trade-offs could be analyzed by the simple flick of a few toggles in our model."

Nick Salvadore, Process Engineer II at Roebling

Nick Salvadore

Process Engineer II, Roebling

Newsletter

Stay up to date

Get the latest Roebling articles, webinar invites, and product updates straight to your inbox.

By subscribing you agree to Roebling’s privacy policy. Unsubscribe anytime.

Copyright © 2026 Roebling. All Rights Reserved.

Newsletter

Stay up to date

Get the latest Roebling articles, webinar invites, and product updates straight to your inbox.

By subscribing you agree to Roebling’s privacy policy. Unsubscribe anytime.

Copyright © 2026 Roebling. All Rights Reserved.

Newsletter

Stay up to date

Get the latest Roebling articles, webinar invites, and product updates straight to your inbox.

By subscribing you agree to Roebling’s privacy policy. Unsubscribe anytime.

Copyright © 2026 Roebling. All Rights Reserved.

We value your privacy

We use cookies to improve site functionality. Some cookies help us understand how visitors use our site.